3sdg
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3sdg.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3sdg", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3sdg| PDB=3sdg | SCENE= }} | ||
- | + | ===Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_22098589}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 22098589 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_22098589}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3sdg]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SDG OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:022098589</ref><references group="xtra"/> | ||
+ | [[Category: Mycobacterium tuberculosis]] | ||
+ | [[Category: Baulard, A R.]] | ||
+ | [[Category: Blondiaux, N.]] | ||
+ | [[Category: Brodin, P.]] | ||
+ | [[Category: Christophe, T.]] | ||
+ | [[Category: Desroses, M.]] | ||
+ | [[Category: Flament, M P.]] | ||
+ | [[Category: Flipo, M.]] | ||
+ | [[Category: Jeon, H K.]] | ||
+ | [[Category: Lecat-Guillet, N.]] | ||
+ | [[Category: Leroux, F.]] | ||
+ | [[Category: Locht, C.]] | ||
+ | [[Category: Mathys, V.]] | ||
+ | [[Category: Piveteau, C.]] | ||
+ | [[Category: Siepmann, J.]] | ||
+ | [[Category: Soror, S H.]] | ||
+ | [[Category: Villemagne, B.]] | ||
+ | [[Category: Villeret, V.]] | ||
+ | [[Category: Willand, N]] | ||
+ | [[Category: Wintjens, R.]] | ||
+ | [[Category: Wohlkonig, A.]] | ||
+ | [[Category: Prez, BD.]] | ||
+ | [[Category: Dna]] | ||
+ | [[Category: Dna binding]] | ||
+ | [[Category: Dna binding protein]] | ||
+ | [[Category: Inhibitor]] | ||
+ | [[Category: Tetr-family]] | ||
+ | [[Category: Transcription repressor-inhibitor complex]] | ||
+ | [[Category: Transcritptional regulatory repressor]] |
Revision as of 08:04, 7 December 2011
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.
Template:ABSTRACT PUBMED 22098589
About this Structure
3sdg is a 1 chain structure with sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.
Reference
- Flipo M, Desroses M, Lecat-Guillet N, Villemagne B, Blondiaux N, Leroux F, Piveteau C, Mathys V, Flament MP, Siepmann J, Villeret V, Wohlkonig A, Wintjens R, Soror SH, Christophe T, Jeon HK, Locht C, Brodin P, Deprez BP, Baulard A, Willand N. Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors. J Med Chem. 2011 Nov 20. PMID:22098589 doi:10.1021/jm200825u
Categories: Mycobacterium tuberculosis | Baulard, A R. | Blondiaux, N. | Brodin, P. | Christophe, T. | Desroses, M. | Flament, M P. | Flipo, M. | Jeon, H K. | Lecat-Guillet, N. | Leroux, F. | Locht, C. | Mathys, V. | Piveteau, C. | Siepmann, J. | Soror, S H. | Villemagne, B. | Villeret, V. | Willand, N | Wintjens, R. | Wohlkonig, A. | Prez, BD. | Dna | Dna binding | Dna binding protein | Inhibitor | Tetr-family | Transcription repressor-inhibitor complex | Transcritptional regulatory repressor